The Physician’s Challenge
Assessment of cardiovascular risk in asymptomatic patients – Cardiovascular disease is one of the leading causes of death globally. To assess risk, doctors typically review traditional risk factors, such as total cholesterol, blood pressure, smoking history, age, gender, lipid profile (HDL/LDL levels), and family history. However, these conventional tests can be poor predictors of future atherothrombotic events. Relying on these factors may result in misclassification of risk. In a major study of 136,905 patients hospitalized with coronary artery disease, only 23% had high LDL levels* (above 130 mg/dl) and would be identified by traditional risk factors. Yet in a large outcome study of 10,000 asymptomatic subjects with a 10 year follow-up (mean age = 53), ultrasound identified 98.6% of future atherothrombotic events.**
The Panasonic Solution – Find a Plaque, Treat It.
We have engineered a product that not only improves your ability to see the underlying disease, but also fits seamlessly into your treatment regimen. Innovative ultrasound imaging technology allows for direct identification of atherosclerotic cardiovascular disease (ASCVD). By combining traditional risk factors with imaging, physicians are able to gather a more comprehensive understanding of their patients’ cardiovascular health. The CardioHealth Station in the hands of a trained professional is the perfect in-office tool. Driven by advanced hardware, it automates many of the steps which a sonographer would usually need to understand and perform, making it easy to start using right away and on your own schedule.
Easy to Integrate into your Practice to Help you Start Making Informed Decisions
A recent study published by physicians out of Mayo Clinic and the University of Southern California assessed how easy it was to train medical residents to use ultrasound imaging to identify plaque and measure CIMT. The conclusion was that it was easy to rapidly train medical residents, who had no prior ultrasound training, to identify ASCVD with an accuracy comparable to experts.* Another major study done in India, under the guidance of leading physicians from Mt. Sinai, sought to determine the feasibility of performing ultrasound imaging in a rural young population with few to no risk factors. The results proved that not only was rapid community screening of subclinical atherosclerosis possible, but also useful for identifying the high prevalence of atherosclerotic cardiovascular disease (ASCVD) where traditional risk factors were not available. **
In most cases, the entire test takes no longer than five minutes allowing you to create a comprehensive cardiovascular risk assessment very quickly. A detailed report is generated based on traditional risk factor scores (FRAMINGHAM, SCORE or PROCAM) and the results of the ultrasound examination (plaque and IMT) are plotted against your choice of a major study, whether it be ARIC, MESA, or CAPS. Developed in close cooperation with key opinion leaders in preventive cardiology and subclinical atherosclerosis imaging, the report is optimized for you and your patients. The combination of schematic and actual ultrasound images to depict wall thickness and arterial plaque may serve as a clever solution to increasing patient adherence to treatment.